MeSH D002561 - cerebrovascular disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001927:Brain diseases
0 Companies
0 Drugs
Success rate
D002561:
Cerebrovascular disorders
0 Companies
0 Drugs
Success rate
D000088323:Vascular depression
0 Companies
0 Drugs
Success rate
D002340:Carotid artery diseases
0 Companies
0 Drugs
Success rate
D002538:Intracranial arteriovenous malformations
0 Companies
0 Drugs
Success rate
D002542:Intracranial embolism and thrombosis
D002545:Brain ischemia
D007969:Periventricular leukomalacia
0 Companies
0 Drugs
Success rate
D015140:Vascular dementia
0 Companies
0 Drugs
Success rate
D018860:Sneddon syndrome
0 Companies
0 Drugs
Success rate
D020144:Basal ganglia cerebrovascular disease
0 Companies
0 Drugs
Success rate
D020214:Cerebrovascular trauma
0 Companies
0 Drugs
Success rate
D020293:Central nervous system vasculitis
0 Companies
0 Drugs
Success rate
D020300:Intracranial hemorrhages
0 Companies
0 Drugs
Success rate
D020301:Intracranial vasospasm
0 Companies
0 Drugs
Success rate
D020521:Stroke
D020765:Intracranial arterial diseases
0 Companies
0 Drugs
Success rate
D055955:Susac syndrome
0 Companies
0 Drugs
Success rate
D059345:Cerebral small vessel diseases
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
24%4/17
Phase 3
5%1/20
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use